NO20080803L - Preparater med forsinket frigjoring og fremgangsmaten for deres fremstilling - Google Patents
Preparater med forsinket frigjoring og fremgangsmaten for deres fremstillingInfo
- Publication number
- NO20080803L NO20080803L NO20080803A NO20080803A NO20080803L NO 20080803 L NO20080803 L NO 20080803L NO 20080803 A NO20080803 A NO 20080803A NO 20080803 A NO20080803 A NO 20080803A NO 20080803 L NO20080803 L NO 20080803L
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- preparation
- delayed release
- release preparations
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Abstract
Oppfinnelsen angår preparater i form av mikrokapsler eller implantater omfattende et bionedbrytbart polymert eller kopolymert tilsetningsmiddel eller en blanding av slike tilsetningsmidler med en inherent viskositet på mellom 0,5 dl/g og 1,6 dl/g i CHCl3 og én aktiv forbindelse eller en blanding av aktive forbindelser, idet det er mulig for nevnte mikrokapsler eller implantater å frigjøre den aktive forbindelse eller blandingen av aktive forbindelser over en forlenget periode på opptil tre måneder eller mer. Disse preparatene kan også omfatte en aktiv bestanddel som har et høyt spesifikt overflateareal.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704837A FR2762318B1 (fr) | 1997-04-18 | 1997-04-18 | Compositions presentant une liberation prolongee et leur procede de preparation |
FR9803666A FR2776516B1 (fr) | 1998-03-25 | 1998-03-25 | Compositions presentant une liberation prolongee et leur procede de preparation |
PCT/FR1998/000773 WO1998047489A1 (fr) | 1997-04-18 | 1998-04-17 | Compositions presentant une liberation prolongee et leur procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080803L true NO20080803L (no) | 1999-11-15 |
Family
ID=26233477
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995063A NO327999B1 (no) | 1997-04-18 | 1999-10-15 | Preparater med forsinket frigjoring |
NO20080803A NO20080803L (no) | 1997-04-18 | 2008-02-14 | Preparater med forsinket frigjoring og fremgangsmaten for deres fremstilling |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995063A NO327999B1 (no) | 1997-04-18 | 1999-10-15 | Preparater med forsinket frigjoring |
Country Status (23)
Country | Link |
---|---|
US (2) | US6217893B1 (no) |
EP (1) | EP0980240B1 (no) |
JP (1) | JP4557312B2 (no) |
CN (2) | CN1313082C (no) |
AR (2) | AR012448A1 (no) |
AT (1) | ATE389388T1 (no) |
AU (1) | AU741964B2 (no) |
BR (1) | BR9808933A (no) |
CA (1) | CA2286575C (no) |
CZ (1) | CZ297078B6 (no) |
DE (1) | DE69839264T2 (no) |
DK (1) | DK0980240T3 (no) |
ES (1) | ES2303353T3 (no) |
HK (1) | HK1027983A1 (no) |
HU (1) | HUP0004297A2 (no) |
IL (1) | IL132217A (no) |
MY (1) | MY118835A (no) |
NO (2) | NO327999B1 (no) |
PL (1) | PL196771B1 (no) |
PT (1) | PT980240E (no) |
RU (1) | RU2198678C2 (no) |
TW (1) | TW577759B (no) |
WO (1) | WO1998047489A1 (no) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
US6303138B1 (en) * | 1999-09-17 | 2001-10-16 | Depuy Orthopaedics | Endothelin-based compositions for enhancing connective tissue repair |
CA2405912A1 (en) * | 2000-04-12 | 2001-10-18 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
JP2004528089A (ja) * | 2001-04-17 | 2004-09-16 | ユニバーシティ・オブ・シェフィールド | メラニン細胞刺激ホルモン(msh)を含む生体適合材料および形成方法 |
US20030143191A1 (en) * | 2001-05-25 | 2003-07-31 | Adam Bell | Chemokine beta-1 fusion proteins |
JP2004535431A (ja) * | 2001-06-22 | 2004-11-25 | サザン バイオシステムズ, インコーポレイテッド | ゼロ次長期放出同軸インプラント |
GB0122113D0 (en) * | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Composition |
ES2545090T3 (es) * | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina y GCSF |
AU2002364587A1 (en) * | 2001-12-21 | 2003-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP1539959A2 (en) * | 2002-09-18 | 2005-06-15 | Centre Hospitalier de l'Université de Montréal (CHUM) | Ghrh analogues |
US7655618B2 (en) | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
NZ541365A (en) * | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
CA2519779A1 (en) * | 2003-03-26 | 2004-10-14 | Teva Pharmaceutical Industries Ltd. | A process for preparing a pharmaceutical active ingredient with high specific surface area |
US20070027073A1 (en) * | 2003-04-08 | 2007-02-01 | Menachem Rubinstein | Long-acting derivatives of pyy agonists |
US8916196B2 (en) | 2003-04-10 | 2014-12-23 | Evonik Corporation | Method for the production of emulsion-based microparticles |
US20070207211A1 (en) * | 2003-04-10 | 2007-09-06 | Pr Pharmaceuticals, Inc. | Emulsion-based microparticles and methods for the production thereof |
CA2523859C (en) * | 2003-04-29 | 2011-08-02 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
EP1651136B1 (en) * | 2003-07-15 | 2017-03-08 | Evonik Corporation | Method for the preparation of controlled release formulations |
CA2533592C (en) * | 2003-07-23 | 2015-11-10 | Pr Pharmaceuticals, Inc. | Controlled release compositions |
KR20050047030A (ko) * | 2003-11-13 | 2005-05-19 | 한미약품 주식회사 | 약물의 캐리어로서 유용한 IgG Fc 단편 및 그의제조방법 |
EP1711159B1 (en) * | 2003-12-30 | 2013-03-20 | Durect Corporation | Solid implants containing a block copolymer for controlled release of a gnrh compound |
WO2005110425A1 (en) | 2004-04-15 | 2005-11-24 | Alkermes, Inc. | Polymer-based sustained release device |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
WO2006052468A2 (en) | 2004-10-27 | 2006-05-18 | University Of Denver | Adrenocorticotropic hormone analogs and related methods |
EP1679065A1 (en) * | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
EP1853227B1 (en) * | 2005-03-02 | 2009-08-05 | The Secretary of State for Defence | Pharmaceutical composition |
US7942867B2 (en) * | 2005-11-09 | 2011-05-17 | The Invention Science Fund I, Llc | Remotely controlled substance delivery device |
PT1968549E (pt) * | 2005-12-22 | 2014-08-29 | Novartis Ag | Formulação de libertação controlada compreendendo octreotida e dois ou mais polímeros de polilactídeo-co-glicolídeo |
EP1984009B1 (en) * | 2006-01-18 | 2012-10-24 | Qps, Llc | Pharmaceutical compositions with enhanced stability |
EP1837014A1 (en) * | 2006-03-21 | 2007-09-26 | Hexal Ag | Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue |
PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
EP2131815A4 (en) * | 2007-03-22 | 2012-11-07 | Alkermes Inc | coacervation |
MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
EP3431077A1 (en) | 2007-06-06 | 2019-01-23 | Debiopharm Research & Manufacturing SA | Slow release pharmaceutical composition made of microparticles |
US20080317865A1 (en) * | 2007-06-20 | 2008-12-25 | Alkermes, Inc. | Quench liquids and washing systems for production of microparticles |
WO2009095450A1 (en) * | 2008-01-30 | 2009-08-06 | Novartis Ag | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
LT2341905T (lt) * | 2008-09-04 | 2020-09-25 | Amylin Pharmaceuticals, Llc | Pailginto atpalaidavimo vaisto formos su nevandeniniais nešikliais |
NZ598686A (en) | 2009-09-28 | 2014-05-30 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
ES2699692T3 (es) * | 2010-01-04 | 2019-02-12 | Mapi Pharma Ltd | Sistema de depósito que comprende acetato de glatiramer |
USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
IT1402654B1 (it) * | 2010-09-20 | 2013-09-13 | Cid S R L | Composizione per il rilascio di principi attivi da dispositivi di impianto |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
CN103163258B (zh) * | 2011-12-09 | 2015-09-23 | 山东绿叶制药有限公司 | 一种测定痕量曲普瑞林的方法 |
CN102552166A (zh) * | 2012-01-09 | 2012-07-11 | 北京化工大学 | 一种溶菌酶/聚(α-氰基丙烯酸异丁酯)载药微球的制备方法 |
EP2823883B1 (en) | 2012-03-08 | 2018-09-19 | Consejo Superior De Investigaciones Científicas (CSIC) | Coating with photochromic properties, method for producing said coating and use thereof applicable to optical articles and glazed surfaces |
AU2013255885C1 (en) | 2012-05-03 | 2018-04-26 | Janssen Sciences Ireland Uc | Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections |
RU2506269C1 (ru) * | 2012-08-03 | 2014-02-10 | Татьяна Георгиевна Емельянова | Фармацевтическая композиция, содержащая физиологически активные гептапептиды, обладающие противосудорожным, анксиолитическим, центральным противовоспалительным и анальгетическим, а также антиалкогольным действием |
WO2014169816A1 (zh) * | 2013-04-18 | 2014-10-23 | 山东绿叶制药有限公司 | 戈舍瑞林缓释微球药物组合物 |
CN103230624A (zh) * | 2013-05-02 | 2013-08-07 | 复旦大学附属上海市第五人民医院 | 一种用于微创埋线治疗的植入材料 |
CN103720663B (zh) * | 2014-01-08 | 2016-04-06 | 昆药集团股份有限公司 | 一种促卵泡激素缓释微球及其制备方法 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US20160106804A1 (en) * | 2014-10-15 | 2016-04-21 | Yuhua Li | Pharmaceutical composition with improved stability |
AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
CA2987209A1 (en) * | 2015-06-10 | 2016-12-15 | Evonik Rohm Gmbh | Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer |
CN107224571A (zh) * | 2016-03-23 | 2017-10-03 | 张巍 | 一种具有坐骨神经保护功能的plga复合微球 |
ITUA20162094A1 (it) | 2016-03-29 | 2017-09-29 | Cid S P A | Perfezionamenti negli stent per il rilascio di principi attivi |
CN105963258B (zh) | 2016-04-26 | 2021-01-22 | 广州帝奇医药技术有限公司 | 一种缓释微粒的制备方法 |
CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
EP3565580B1 (en) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel |
CA3050086A1 (en) | 2017-03-26 | 2018-10-04 | Mapi Pharma Ltd. | Glatiramer depot systems for treating progressive forms of multiple sclerosis |
CN107375910B (zh) * | 2017-07-12 | 2020-03-24 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | PTHrP在制备治疗男性性腺功能低下综合征中的应用 |
CN110547969A (zh) * | 2019-09-03 | 2019-12-10 | 杭州诺泰澳赛诺医药技术开发有限公司 | 一种高比表面积纳米级缓释微粉的生产工艺及设备 |
IT202000017191A1 (it) | 2020-07-15 | 2022-01-15 | Xbrane Biopharma Ab | Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale |
CN112156170B (zh) * | 2020-11-03 | 2022-10-21 | 北京康欣东弘医药科技有限公司 | 可供皮下注射的曲普瑞林缓释微球及其制备方法和用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH661206A5 (fr) | 1983-09-23 | 1987-07-15 | Debiopharm Sa | Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes. |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
DE3734223A1 (de) * | 1987-10-09 | 1989-04-20 | Boehringer Ingelheim Kg | Implantierbares, biologisch abbaubares wirkstofffreigabesystem |
US5021554A (en) * | 1989-02-24 | 1991-06-04 | Eli Lilly And Company | Process for protein particle size reduction using a fluid-energy mill |
GB2246514B (en) * | 1990-08-01 | 1993-12-15 | Scras | Sustained release pharmaceutical compositions and the preparation of particles for use therein |
GB9016885D0 (en) * | 1990-08-01 | 1990-09-12 | Scras | Sustained release pharmaceutical compositions |
DE4041563A1 (de) * | 1990-12-22 | 1992-06-25 | Sanol Arznei Schwarz Gmbh | Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
DE4223169C1 (de) * | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
FR2693905B1 (fr) | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
ATE236655T1 (de) * | 1993-01-06 | 2003-04-15 | Kinerton Ltd | Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden |
US5785976A (en) * | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US6117455A (en) | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
US6136346A (en) * | 1995-04-14 | 2000-10-24 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
CZ288147B6 (en) * | 1995-06-07 | 2001-05-16 | Alkermes Inc | Preparation for prolonged release of human growth hormone |
JPH11509862A (ja) | 1996-01-24 | 1999-08-31 | アメリカ合衆国 | 新規「バーストフリー」持続放出型ポリ(ラクチド/グリコリド)微小球 |
AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
-
1998
- 1998-04-16 AR ARP980101756A patent/AR012448A1/es not_active Application Discontinuation
- 1998-04-16 TW TW087105802A patent/TW577759B/zh not_active IP Right Cessation
- 1998-04-16 MY MYPI98001698A patent/MY118835A/en unknown
- 1998-04-17 RU RU99124209/14A patent/RU2198678C2/ru not_active IP Right Cessation
- 1998-04-17 HU HU0004297A patent/HUP0004297A2/hu unknown
- 1998-04-17 BR BR9808933-1A patent/BR9808933A/pt not_active Application Discontinuation
- 1998-04-17 DK DK98921551T patent/DK0980240T3/da active
- 1998-04-17 AU AU74363/98A patent/AU741964B2/en not_active Ceased
- 1998-04-17 EP EP98921551A patent/EP0980240B1/fr not_active Revoked
- 1998-04-17 US US09/403,058 patent/US6217893B1/en not_active Expired - Lifetime
- 1998-04-17 CZ CZ0362699A patent/CZ297078B6/cs not_active IP Right Cessation
- 1998-04-17 ES ES98921551T patent/ES2303353T3/es not_active Expired - Lifetime
- 1998-04-17 AT AT98921551T patent/ATE389388T1/de active
- 1998-04-17 WO PCT/FR1998/000773 patent/WO1998047489A1/fr active IP Right Grant
- 1998-04-17 CN CNB031545998A patent/CN1313082C/zh not_active Expired - Fee Related
- 1998-04-17 PL PL336296A patent/PL196771B1/pl unknown
- 1998-04-17 CA CA2286575A patent/CA2286575C/fr not_active Expired - Fee Related
- 1998-04-17 IL IL13221798A patent/IL132217A/en not_active IP Right Cessation
- 1998-04-17 JP JP54515098A patent/JP4557312B2/ja not_active Expired - Fee Related
- 1998-04-17 PT PT98921551T patent/PT980240E/pt unknown
- 1998-04-17 DE DE69839264T patent/DE69839264T2/de not_active Expired - Lifetime
- 1998-04-17 CN CNB988052202A patent/CN1144584C/zh not_active Expired - Fee Related
-
1999
- 1999-10-15 NO NO19995063A patent/NO327999B1/no not_active IP Right Cessation
-
2000
- 2000-11-06 US US09/707,372 patent/US6475507B1/en not_active Expired - Lifetime
- 2000-11-23 HK HK00107498A patent/HK1027983A1/xx not_active IP Right Cessation
-
2007
- 2007-07-05 AR ARP070102999A patent/AR061828A2/es not_active Application Discontinuation
-
2008
- 2008-02-14 NO NO20080803A patent/NO20080803L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080803L (no) | Preparater med forsinket frigjoring og fremgangsmaten for deres fremstilling | |
NO20015601L (no) | Enzym-instantformuleringer av enzymer for dyrefôr | |
DE69734832D1 (de) | Zusammensetzungen und verfahren zum stimulieren von knochenwachstum | |
BR9912691A (pt) | Composições pesticidas e método de controle de pragas | |
WO2002046170A8 (en) | Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto | |
CA2304669A1 (en) | Acidic, thickened cleaning and disinfecting compositions | |
BR9911976B1 (pt) | composições de limpeza e lavandeira, método de distribuição de fragráncia residual a uma superfìcie e uso. | |
TR199903152T2 (xx) | Zararl� biyo-organizmalar� denetlemek i�in bile�im ve bu bile�imin kullan�m�yla zararl� biyo-organizmalar�n denetlenmesi y�ntemi. | |
CA2269592A1 (en) | Composition and method for treating plants with exogenous chemicals | |
ES2103289T3 (es) | Derivados de pirimidina y composiciones herbicidas que los contienen. | |
CA2300682A1 (en) | Method of improving viscosity stability of aqueous compositions | |
RS50360B (sr) | Farmaceutske formulacije derivata platine | |
NO970512L (no) | Nye heteroaryl-oksazolidinoner | |
BR9912029B1 (pt) | composição amaciante e método de liberação da fragráncia residual para uma superfìcie. | |
MY115071A (en) | Efficacy enhancer for agricultural chemicals and agricultural chemical compositions | |
BR9807183A (pt) | Mistura sólida e processos para o controle de vegetação indesejada e para a preparação de formulações herbicidas | |
WO2000051993A3 (en) | Dihetero-substituted metalloprotease inhibitors | |
CA2252039A1 (en) | Isatin derivatives as acetylcholinesterase inhibitors and analgesics | |
WO2001091738A3 (en) | Naaladase inhibitors for treating amyotrophic lateral sclerosis | |
YU29300A (sh) | Katalizovane reakcije prelaznog metala bazirane na hiralnim amin oksazolinil ligandima | |
BR9806805A (pt) | Mistura sólida, e, processos para controlar o crescimento de plantas indesejáveis e para preparar formulações de herbicidas. | |
WO1997020462A3 (en) | Lignin-basedpest control formulations | |
ATE455548T1 (de) | Mittel und verfahren zum schutz, zur behandlung und reparatur von bindegewebe | |
PT94957A (pt) | Processo para preparacao de composicoes farmaceuticas para tratamento da hipertrofia e hiperplasia cardiais e vasculares compreendendo um inibidor do enzima de conversao da angiotensina | |
NO884523L (no) | Joderte polymerer, fremgangsmaate for deres fremstilling og deres anvendelse som kontrastmidler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |